secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACADIA PHARMACEUTICALS INC (ACAD)
CIK:        0001070494
Form:       8-K
Filed at:   2022-04-08T23:59:59+00:00
Accession:  0001193125-22-100541
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Acadia grants retention RSUs to CEO, President, and General Counsel
-------------------------------------------------------------------

- CEO Stephen R. Davis receives 277,331 RSUs; President Srdjan R. Stankovic 144,695 RSUs; EVP Gen. Counsel Austin D. Kim 96,463 RSUs.
- RSUs vest: 37.5% at 18 months, 12.5% at 2 years, 25% at 3 years, 25% at 4 years from grant date.
- Awards granted under Acadia's 2010 Equity Incentive Plan, with accelerated vesting in certain circumstances.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070494/000119312522100541/0001193125-22-100541-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070494/000119312522100541/d353045d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-100541

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer